effecty semaglutide Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Exploring beyond numeric weight loss:

Thats the question Novo Nordisk is betting its future on

Tirzepatide still takes the cake over Cagrilintide for comprehensive metabolic optimization, and Retatrutide is superior to either option

Patients should know about allodynia as a possibility, understand what to watch for, and have a plan for what to do if symptoms develop

At the helm is board-certified physician Jennifer Ukwu, MD, whose expertise spans family medicine, womens health, obesity medicine, and nutrition management

Peptide Research in Canada Where do things stand in 2026

Collectively, numerous retrospective and large database studies have identified potential benefits of GLP-1RA in ocular disease, indicating a need for prospective trials to more definitively identify protective effects and integrate this medication class into the ophthalmology toolbox